Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study-Reference-Cited by-同舟云学术

Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study

Published:2020-07 Issue:3 Volume:10 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Wang Peng‐Xiang¹²,Sun Yun‐Fan¹²,Zhou Kai‐Qian¹²,Cheng Jian‐Wen¹²,Hu Bo¹²,Guo Wei³,Yin Yue¹²,Huang Jun‐Feng⁴,Zhou Jian¹²⁵,Fan Jia¹²⁵,Cheung Tan To⁶,Qu Xu‐Dong⁷,Yang Xin‐Rong¹^ORCID

Affiliation:

1. Department of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan HospitalFudan University Shanghai China

2. Key Laboratory of Carcinogenesis and Cancer InvasionMinistry of Education Shanghai China

3. Department of Laboratory Medicine, Zhongshan HospitalFudan University Shanghai China

4. Department of Intensive Care Medicine, Zhongshan HospitalFudan University Shanghai China

5. Institutes of Biomedical SciencesFudan University Shanghai China

6. Department of SurgeryThe University of Hong Kong Hong Kong China

7. Department of Intervention Radiology, Zhongshan HospitalFudan University Shanghai China

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.137

Reference27 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. Recurrence of Hepatocellular Cancer After Resection

3. AASLD guidelines for the treatment of hepatocellular carcinoma

4. Tumour microenvironment: informing on minimal residual disease in solid tumours;Pantel K;Nat Rev Clin Oncol,2017

5. Perioperative events influence cancer recurrence risk after surgery

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects;Heliyon;2024-08

2. Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis;Journal of Cancer Research and Clinical Oncology;2024-06-25

3. A novel stratification scheme combined with internal arteries in CT imaging for guiding postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a retrospective cohort study;International Journal of Surgery;2024-02-21

4. A multicenter case–controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3–5 cm hepatocellular carcinoma in patients aged 60 and older;International Journal of Surgery;2024-02-05

5. Multi-omic features and clustering phenotypes of circulating tumor cells associated with metastasis and clinical outcomes;International Review of Cell and Molecular Biology;2024